A mild exanthematous inflammation of unknown etiology. It is characterized by the presence of salmon-colored maculopapular lesions. The most striking feature is the arrangement of the lesions such that the long axis is parallel to the lines of cleavage. The eruptions are usually generalized, affecting chiefly the trunk, and the course is often self-limiting.
A name originally applied to a group of skin diseases characterized by the formation of fine, branny scales, but now used only with a modifier. (Dorland, 27th ed)
A chronic skin disease characterized by small follicular papules, disseminated reddish-brown scaly patches, and often, palmoplantar hyperkeratosis. The papules are about the size of a pin and topped by a horny plug.
A subgroup of PARAPSORIASIS itself divided into acute and chronic forms. The acute form is characterized by the abrupt onset of a generalized, reddish-brown, maculopapular eruption. Lesions may be vesicular, hemorrhagic, crusted, or necrotic. Histologically the disease is characterized by epidermal necrolysis. The chronic form shows milder skin changes with necrosis.
A mitosporic fungal genus that causes a variety of skin disorders. Malassezia furfur (Pityrosporum orbiculare) causes TINEA VERSICOLOR.
An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Superficial infections of the skin or its appendages by any of various fungi.
The use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin. This is the part of the sun's spectrum that causes sunburn and tanning. Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing.
An autosomal recessive trait with impaired cell-mediated immunity. About 15 human papillomaviruses are implicated in associated infection, four of which lead to skin neoplasms. The disease begins in childhood with red papules and later spreads over the body as gray or yellow scales.
A species in the genus ROSEOLOVIRUS, of the family HERPESVIRIDAE. It was isolated from activated, CD4-positive T-lymphocytes taken from the blood of a healthy human.
Complex pain syndrome with unknown etiology, characterized by constant or intermittent generalized vulva pain (Generalized vulvodynia) or localized burning sensations in the VESTIBULE area when pressure is applied (Vestibulodynia, or Vulvar Vestibulitis Syndrome). Typically, vulvar tissue with vulvodynia appears normal without infection or skin disease. Vulvodynia impacts negatively on a woman's quality of life as it interferes with sexual and daily activities.
The term applied to a group of relatively uncommon inflammatory, maculopapular, scaly eruptions of unknown etiology and resistant to conventional treatment. Eruptions are both psoriatic and lichenoid in appearance, but the diseases are distinct from psoriasis, lichen planus, or other recognized dermatoses. Proposed nomenclature divides parapsoriasis into two distinct subgroups, PITYRIASIS LICHENOIDES and parapsoriasis en plaques (small- and large-plaque parapsoriasis).
Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.
Infection with ROSEOLOVIRUS, the most common in humans being EXANTHEMA SUBITUM, a benign disease of infants and young children.
The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
'Skin diseases' is a broad term for various conditions affecting the skin, including inflammatory disorders, infections, benign and malignant tumors, congenital abnormalities, and degenerative diseases, which can cause symptoms such as rashes, discoloration, eruptions, lesions, itching, or pain.

Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. (1/13)

Sixteen cases of either a pityriasiform or discoid eczematous rash occurring in patients with rheumatoid arthritis receiving treatment with gold (sodium aurothiomalate and auranofin) were studied. The results suggest that this is a dose related, not allergic, reaction to gold. The development of this rash is not an absolute indication to stop treatment with gold. Control can often be effected with potent topical steroids or a reduction in the dose or frequency of treatment with gold.  (+info)

Clinical diagnosis of common scalp disorders. (2/13)

Scalp skin is unique on the body due to the density of hair follicles and high rate of sebum production. These features make it susceptible to superficial mycotic conditions (dandruff, seborrheic dermatitis, and tinea capitis), parasitic infestation (pediculosis capitis), and inflammatory conditions (psoriasis). Because these scalp conditions share similar clinical manifestations of scaling, inflammation, hair loss, and pruritus, differential diagnosis is critically important. Diagnostic techniques and effective treatment strategies for each of the above conditions will be discussed.  (+info)

Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta. (3/13)

Lymphomatoid papulosis (LyP) and pityriasis lichenoides et varioliformis acuta (PLEVA) are benign self-healing cutaneous eruptions that may be clinically and histologically similar. However LyP has a 5% to 20% risk of associated lymphoid malignancy, whereas PLEVA does not. To determine whether the immunophenotype of lymphoid cells is useful in the distinction of these two disorders, the pattern of expression of lymphoid cell lineage and activation antigens in nine cases of LyP and seven cases of PLEVA were compared. In all cases of LyP most larger cells expressed the activation antigen Ki-1 (CD30) and lacked expression of the T-cell antigen CD7 and at least one other T-cell antigen (CD2, CD3, CD5). In contrast, CD30-antigen expression was rare or absent in PLEVA, CD3- and CD7-antigen expression was found in all cases, and diminished expression of T-cell antigens (CD2 and CD5) was seen in only one case. Diffuse expression of HLA-DR antigen by epidermal keratinocytes was found in a greater proportion of PLEVA cases (6 of 7) than LyP cases (3 of 6). In addition, CD8+ cells predominated at the dermal/epidermal junction in 3 of 6 cases of PLEVA but in only 1 of 7 cases of LyP. We conclude that LyP and PLEVA can be distinguished immunohistochemically in most, if not all, cases. Furthermore these results suggest that LyP and PLEVA are separate disorders, thus accounting for their variable prognoses.  (+info)

Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature. (4/13)

 (+info)

Superficial fungal infections: clinical and epidemiological study in adolescents from marginal districts of Lima and Callao, Peru. (5/13)

BACKGROUND: Since limited data on superficial fungal infections in teenagers exist in our setting, this study provides the first description of the clinical and epidemiological characteristics of these infections among teenagers in Lima and Callao, Peru. METHODOLOGY: The study involved 1,387 adolescents in five public schools from June to November 2006. Participants were examined for superficial fungal lesions. Samples of skin scrapings for microbiological investigations were obtained from suspicious lesions. RESULTS: A total of 257 subjects were identified with suspected superficial fungal infections. Microbiological assessment was positive for 166 of 257 (64.59%). The average prevalence was 12.61% with variation between different districts. Males were more affected (64%) than females (36%) (p = 0.001). Pet ownership, use of public baths, and wearing sneakers were identified as important risk factors. The majority (61.5%) of the subjects presented with itching although 38.5% were asymptomatic. Tinea pedis was observed in 62.6%, onychomycosis in 24% and pityriasis versicolor in 10.8%. Dermatophytes were isolated in 105 cases with T. rubrum being identified in 86 cases (59.7%), T. mentagrophytes in 14 (9.7%) and yeast in 39 (23.4%). Malassezia spp. was found by direct examination in 18 cases (12.5%), C. kruseii in 8 cases (5.6%), and C. albicans in 2 cases (1.4%). Mixed infections were found in 22 cases. CONCLUSIONS: Superficial fungal infection manifesting as tinea pedis, onychomycosysis and tinea versicolor is prevalent in our setting. As many infections remain asymptomatic, regular examination of this population is advocated. The associated risk factors for these infections also need to be addressed.  (+info)

Pityriasis rotunda. (6/13)

A 42-year-old man presented with asymptomatic, sharply-demarcated, round, scaly lesions on his forearms that had been present for several months. A skin biopsy specimen was consistent with pityriasis rotunda. Pityriasis rotunda is a disorder of keratinization, which is thought to be a form of acquired ichthyosis, a delayed presentation of congenital ichthyosis, or a cutaneous manifestation of systemic disease. Patients with pityriasis rotunda may be classified into one of two groups, which are based on ethnicity, number of lesions, family history, and association with systemic diseases. Treatment is challenging, but the use of lactic acid lotion and oral vitamin A has shown some promise.  (+info)

Pityriasis amiantacea: clinical-dermatoscopic features and microscopy of hair tufts. (7/13)

 (+info)

A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health. (8/13)

 (+info)

Pityriasis rosea is a common, self-limited skin condition characterized by the development of oval or round, scaly, pinkish, inflamed patches on the skin. The initial lesion, known as the "herald patch," often appears before other lesions and measures 2-10 cm in diameter. It usually starts as a single, solitary, scaly, raised patch on the trunk that precedes the generalized eruption by about 1-2 weeks. The rash typically spreads to involve the chest, abdomen, back, arms, and legs, sparing the face, palms, and soles.

The rash is often asymptomatic but can be pruritic (itchy) in some cases. It usually resolves within 6-12 weeks without any treatment, although topical treatments such as corticosteroids or antihistamines may be used to relieve itching. The exact cause of pityriasis rosea is not known, but it is thought to be caused by a viral infection. It is more common in young adults and is more prevalent in the spring and fall seasons.

Pityriasis is a general term used to describe a group of skin conditions characterized by scaling. It includes several specific types, the most common being Pityriasis rosea and Pityriasis simplex capillitii (also known as dandruff).

1. Pityriasis rosea: This is a temporary skin rash that often begins with a single, round, scaly patch on the chest, abdomen, or back. A few days to weeks later, more patches appear. These patches are oval and scaly, and they may be pink, red, or tan. The rash usually lasts about 6-8 weeks.

2. Pityriasis simplex capillitii: This is a very common condition characterized by flaking or scaling of the scalp, which is often referred to as dandruff.

The term "pityriasis" comes from the Greek word "pitýrios," which means "bran."

Pityriasis rubra pilaris (PRP) is a rare, chronic inflammatory skin disorder characterized by the development of reddish orange scaly patches and thickened plaques on the skin. It primarily affects the scalp, face, knees, elbows, and palms and soles. The condition can also cause reddening and thickening of the skin over the entire body in severe cases.

The key features of PRP include follicular papules (small bumps around hair follicles) that may be surrounded by a white collarette of scale, and areas of skin that are redder than normal (erythema). The condition can also cause nail changes, such as thickening and ridging.

PRP is thought to be caused by an abnormal immune response, although the exact cause is not known. It can affect people of all ages, but it is most commonly seen in children and adults between 40-60 years old. The condition typically progresses through several stages, with periods of worsening symptoms followed by periods of improvement or remission.

Treatment for PRP may include topical therapies, such as corticosteroids or retinoids, as well as systemic treatments, such as immunosuppressive drugs or biologics. The choice of treatment depends on the severity and extent of the condition, as well as other factors.

Pityriasis lichenoides is a group of skin disorders characterized by scaly, red or purple-red papules (small, raised bumps) that can progress to vesicles or pustules and often leave behind a tan or brown discoloration as they resolve. The two main types are pityriasis lichenoides chronica (PLC) and pityriasis lichenoides et varioliformis acuta (PLEVA). PLC is a more chronic, milder form with scaly pink-red papules that can last for months to years, while PLEVA is a more acute form characterized by sudden onset of widespread, eruptive papules and vesicles that may heal with varioliform (pockmarked) scarring. The exact cause of pityriasis lichenoides is unknown, but it's thought to be related to an immune response to an infectious agent or other trigger. Treatment options include topical corticosteroids, phototherapy, and systemic medications such as antibiotics or immunosuppressants.

Malassezia is a genus of fungi (specifically, yeasts) that are commonly found on the skin surfaces of humans and other animals. They are part of the normal flora of the skin, but under certain conditions, they can cause various skin disorders such as dandruff, seborrheic dermatitis, pityriasis versicolor, and atopic dermatitis.

Malassezia species require lipids for growth, and they are able to break down the lipids present in human sebum into fatty acids, which can cause irritation and inflammation of the skin. Malassezia is also associated with fungal infections in people with weakened immune systems.

The genus Malassezia includes several species, such as M. furfur, M. globosa, M. restricta, M. sympodialis, and others. These species can be identified using various laboratory methods, including microscopy, culture, and molecular techniques.

Acitretin is a synthetic form of retinoic acid, which is a type of vitamin A. It is used to treat severe psoriasis and other skin conditions. Acitretin works by slowing down the rapid growth of skin cells that cause the symptoms of psoriasis. It comes in the form of a capsule and is taken orally.

Common side effects of acitretin include dryness of the skin, lips, and mouth, itching, peeling, redness, or stickiness of the palms and soles, hair loss, and changes in nail growth. Less common but more serious side effects can include liver damage, increased levels of lipids in the blood, and birth defects if taken during pregnancy.

It is important to note that acitretin can cause birth defects, so women who are pregnant or planning to become pregnant should not take this medication. Additionally, because acitretin can remain in the body for a long time, it is recommended that women of childbearing age use effective contraception while taking this medication and for at least three years after stopping it.

Dermatomycoses are a group of fungal infections that affect the skin, hair, and nails. These infections are caused by various types of fungi, including dermatophytes, yeasts, and molds. Dermatophyte infections, also known as tinea, are the most common type of dermatomycoses and can affect different areas of the body, such as the scalp (tinea capitis), beard (tinea barbae), body (tinea corporis), feet (tinea pedis or athlete's foot), hands (tinea manuum), and nails (tinea unguium or onychomycosis). Yeast infections, such as those caused by Candida albicans, can lead to conditions like candidal intertrigo, vulvovaginitis, and balanitis. Mold infections are less common but can cause skin disorders like scalded skin syndrome and phaeohyphomycosis. Dermatomycoses are typically treated with topical or oral antifungal medications.

Ultraviolet (UV) therapy, also known as phototherapy, is a medical treatment that uses ultraviolet light to treat various skin conditions. The UV light can be delivered through natural sunlight or artificial sources, such as specialized lamps or lasers.

In medical settings, controlled doses of UV light are used to target specific areas of the skin. The most common type of UV therapy is narrowband UVB (NB-UVB) phototherapy, which uses a specific wavelength of UVB light to treat conditions such as psoriasis, eczema, vitiligo, and dermatitis.

The goal of UV therapy is to reduce inflammation, slow skin cell growth, and improve the overall appearance of the skin. It is important to note that while UV therapy can be effective in treating certain skin conditions, it also carries risks such as skin aging and an increased risk of skin cancer. Therefore, it should only be administered under the supervision of a qualified healthcare professional.

Epidermodysplasia verruciformis (EV) is a rare genetic skin disorder characterized by the development of scaly macules and papules that can progress to malignant lesions. It is caused by mutations in the EVER1 or EVER2 genes, which lead to an increased susceptibility to human papillomavirus (HPV) infection. The condition typically presents in childhood or early adulthood and affects both sexes equally.

The skin abnormalities associated with EV are often described as "wart-like" and can appear anywhere on the body, but they most commonly affect sun-exposed areas such as the hands, arms, and face. The lesions may be flat or slightly raised, and they can vary in color from white to brown or gray. In some cases, the lesions may become thickened and crusted, and they can be pruritic (itchy) or painful.

People with EV are at an increased risk of developing skin cancer, particularly squamous cell carcinoma (SCC). The SCCs associated with EV tend to occur at a younger age than those that develop in the general population, and they often arise within existing EV lesions. Regular skin examinations and sun protection measures are recommended for individuals with EV to help prevent the development of skin cancer.

Treatment options for EV include topical therapies such as retinoids, immunomodulators, and chemotherapeutic agents, as well as systemic therapies such as antiviral medications and interferon. Surgical excision may be necessary for the treatment of malignant lesions.

Human Herpesvirus 7 (HHV-7) is a species of the Herpesviridae family and Betaherpesvirinae subfamily. It is a double-stranded DNA virus that primarily infects human hosts. HHV-7 is closely related to Human Herpesvirus 6 (HHV-6) and both viruses share many biological and biochemical properties.

HHV-7 is typically acquired in early childhood, with most people becoming infected before the age of five. Primary infection with HHV-7 can cause a mild illness known as exanthema subitum or roseola infantum, which is characterized by fever and a rash. However, many HHV-7 infections are asymptomatic.

After initial infection, HHV-7 becomes latent in the host's immune cells, particularly CD4+ T-lymphocytes. The virus can reactivate later in life, causing various clinical manifestations such as chronic fatigue syndrome, seizures, and exacerbation of atopic dermatitis. HHV-7 has also been implicated in the development of certain malignancies, including lymphoproliferative disorders and some types of brain tumors.

Like other herpesviruses, HHV-7 establishes a lifelong infection in its human host, with periodic reactivation throughout the individual's lifetime.

Vulvodynia is a chronic pain condition that affects the vulva, which is the external female genital area. The main symptom is persistent, often burning or irritating pain without an identifiable cause. Some women may experience pain only when the area is touched (provoked vulvodynia), while others have constant pain (unprovoked vulvodynia).

The pain can significantly affect a woman's quality of life, making everyday activities like sitting, wearing tight clothes, or having sex uncomfortable or even unbearable. The exact cause of vulvodynia is not known, but it may be associated with nerve damage or irritation, hormonal changes, muscle spasms, allergies, or past genital infections. Treatment often involves a multidisciplinary approach and can include medication, physical therapy, lifestyle changes, and counseling.

Parapsoriasis is a term used to describe two uncommon, chronic, and relatively benign inflammatory skin conditions. These are small plaque parapsoriasis (SPP) and large plaque parapsoriasis (LPP), also known as retiform or digitate dermatosis of Köbner.

Small plaque parapsoriasis is characterized by scaly, thin, pink to red patches or plaques, usually less than 3-5 cm in diameter. The lesions are often asymptomatic or mildly pruritic and can be found on the trunk and proximal extremities.

Large plaque parapsoriasis presents as larger, irregularly shaped, scaly patches or thin plaques, typically greater than 5 cm in diameter. The lesions are often asymptomatic but may occasionally be pruritic. LPP is considered a precursor to a rare cutaneous T-cell lymphoma called mycosis fungoides, especially when the lesions become thicker or more numerous over time.

It's important to note that these conditions can sometimes be challenging to diagnose and may require a skin biopsy for accurate diagnosis. Dermatologists and pathologists should carefully evaluate the clinical presentation, histopathological features, and any potential progression to ensure appropriate management.

Ketoconazole is an antifungal medication that is primarily used to treat various fungal infections, including those caused by dermatophytes, Candida, and pityrosporum. It works by inhibiting the synthesis of ergosterol, a crucial component of fungal cell membranes, which leads to increased permeability and ultimately results in fungal cell death.

Ketoconazole is available as an oral tablet for systemic use and as a topical cream or shampoo for localized applications. The oral formulation is used to treat severe or invasive fungal infections, while the topical preparations are primarily indicated for skin and scalp infections, such as athlete's foot, ringworm, jock itch, candidiasis, and seborrheic dermatitis.

Common side effects of oral ketoconazole include nausea, vomiting, headache, and altered liver function tests. Rare but serious adverse reactions may include hepatotoxicity, adrenal insufficiency, and interactions with other medications that can affect the metabolism and elimination of drugs. Topical ketoconazole is generally well-tolerated, with local irritation being the most common side effect.

It's important to note that due to its potential for serious liver toxicity and drug-drug interactions, oral ketoconazole has been largely replaced by other antifungal agents, such as fluconazole and itraconazole, which have more favorable safety profiles. Topical ketoconazole remains a valuable option for treating localized fungal infections due to its effectiveness and lower risk of systemic side effects.

Roseolovirus infections are typically caused by human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7). The most common manifestation of roseolovirus infection is exanthem subitum, also known as roseola infantum or sixth disease, which primarily affects children aged 6 months to 2 years.

The infection usually begins with a fever that can last for up to a week, followed by the appearance of a rash once the fever subsides. The rash is typically pinkish-red, maculopapular (consisting of both flat and raised lesions), and appears on the trunk, spreading to the face, neck, and extremities. It usually lasts for 1-2 days.

In addition to exanthem subitum, roseolovirus infections can also cause a variety of other clinical manifestations, including febrile seizures, hepatitis, pneumonitis, myocarditis, and encephalitis. HHV-6 and HHV-7 have also been associated with several chronic diseases, such as chronic fatigue syndrome, multiple sclerosis, and certain malignancies.

Transmission of roseolovirus occurs through saliva and other bodily fluids, and primary infection is usually acquired during childhood. Once infected, the virus remains latent in the body and can reactivate later in life, although reactivation rarely causes symptoms.

In medical terms, the skin is the largest organ of the human body. It consists of two main layers: the epidermis (outer layer) and dermis (inner layer), as well as accessory structures like hair follicles, sweat glands, and oil glands. The skin plays a crucial role in protecting us from external factors such as bacteria, viruses, and environmental hazards, while also regulating body temperature and enabling the sense of touch.

Skin diseases, also known as dermatological conditions, refer to any medical condition that affects the skin, which is the largest organ of the human body. These diseases can affect the skin's function, appearance, or overall health. They can be caused by various factors, including genetics, infections, allergies, environmental factors, and aging.

Skin diseases can present in many different forms, such as rashes, blisters, sores, discolorations, growths, or changes in texture. Some common examples of skin diseases include acne, eczema, psoriasis, dermatitis, fungal infections, viral infections, bacterial infections, and skin cancer.

The symptoms and severity of skin diseases can vary widely depending on the specific condition and individual factors. Some skin diseases are mild and can be treated with over-the-counter medications or topical creams, while others may require more intensive treatments such as prescription medications, light therapy, or even surgery.

It is important to seek medical attention if you experience any unusual or persistent changes in your skin, as some skin diseases can be serious or indicative of other underlying health conditions. A dermatologist is a medical doctor who specializes in the diagnosis and treatment of skin diseases.

No FAQ available that match "pityriasis"

No images available that match "pityriasis"